LifeVantage Corporation Stock News

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to hit the market and disrupt the medical sector. These treatments are permitted when drugs are listed on the FDA's list of drug shortages.

LifeVantage Corporation's Q2/FY2025 results were boosted by the successful launch of the MindBody GLP-1 system. LFVN revenues jumped by more than 40% on a sequential basis, while free cash flow of $8.7 million represented a new multi-year high. However, elevated commissions and incentive expenses impacted profitability, thus resulting in a rather mediocre Adjusted EBITDA margin of 9.6%.

LifeVantage Corporation (NASDAQ:LFVN ) Q2 2025 Earnings Conference Call February 5, 2025 4:30 PM ET Company Participants Reed Anderson – Managing Director-ICR Steve Fife – President and Chief Executive Officer Carl Aure – Chief Financial Officer Conference Call Participants Aaron Wukmir – Lake Street Capital Markets Alex Fuhrman – Craig-Hallum Capital Group Doug Lane – Water Tower Research Oper...

SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid March 17, 2025 to all stockholders of r...

SALT LAKE CITY, Jan. 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its second quarter ended December 31, 2024, after the stock market closes on Wednesday, February 5, 2025. The Company will hold a...

Technology leader brings decades of expertise in innovation, scalability and customer-focused solutions to accelerate LifeVantage's growth and digital transformation Technology leader brings decades of expertise in innovation, scalability and customer-focused solutions to accelerate LifeVantage's growth and digital transformation

New Innovations and Incentives Empower Consultants to Accelerate Business Growth in 2025 New Innovations and Incentives Empower Consultants to Accelerate Business Growth in 2025

The 'Undercovered' Dozen series highlights lesser-covered stocks, offering investment ideas and encouraging discussion among investors. Pacifica Yield highlights Brookfield Infrastructure's subordinated notes with a 32% discount opportunity and a 7.2% yield, backed by a strong balance sheet and diversified assets. Cerence Inc.'s partnership with Nvidia boosts its AI capabilities according to Ut...